AVBP

ArriVent BioPharma, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1868279Held by 5 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

5 managers · Q2 2026 13F

13F bookWeight

Hillhouse Capital Advisors

Hillhouse Capital AdvisorsPosition history →

16.4%

—

$136.5M

$0.83B13F book · 2026-06-30

Vivo Capital

Vivo CapitalPosition history →

5.3%

+89.9%

$58.4M

$1.10B13F book · 2026-06-30

Suvretta Capital Management

Suvretta Capital ManagementPosition history →

3.3%

+2.6%

$156.9M

$4.76B13F book · 2026-06-30

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

2.0%

—

$105.2M

$5.25B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.01%

+30.8%

$1.6M

$21.33B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.